01 1Auro Peptides Limited
01 1GANIRELIX ACETATE
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2021-08-30
Pay. Date : 2021-07-13
DMF Number : 36108
Submission : 2021-07-14
Status : Active
Type : II
20
Auro Peptides Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is GANIRELIX ACETATE, with a corresponding US DMF Number 36108.
Remarkably, this DMF maintains an Active status since its submission on July 14, 2021, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 30, 2021, and payment made on July 13, 2021, indicating their dedication to facilitating drug approvals, Categorized as Type II
